Breast adenocarcinoma Invasive Core biopsy | Breast adenocarcinoma Invasive Incisional biopsy | Breast adenocarcinoma Invasive Excisional biopsy
Item
histologic diagnosis of invasive adenocarcinoma of the breast diagnosed by core, incisional, or excisional biopsy.
boolean
C0858252 (UMLS CUI [1,1])
C0205281 (UMLS CUI [1,2])
C1318309 (UMLS CUI [1,3])
C0858252 (UMLS CUI [2,1])
C0205281 (UMLS CUI [2,2])
C0184922 (UMLS CUI [2,3])
C0858252 (UMLS CUI [3,1])
C0205281 (UMLS CUI [3,2])
C0184921 (UMLS CUI [3,3])
Staging criteria Fulfill | Primary tumor Operable TNM clinical staging | Lymph nodes Ipsilateral TNM clinical staging | Neoplasm Metastasis Absent
Item
all of the following staging criteria must be met: primary tumor must be operable and staged as ct1-3 by clinical evaluation. ipsilateral nodes must be cn0-1 by clinical evaluation. no evidence of metastatic disease (m0).
boolean
C0332305 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
C0677930 (UMLS CUI [2,1])
C0205188 (UMLS CUI [2,2])
C3258246 (UMLS CUI [2,3])
C0024204 (UMLS CUI [3,1])
C0441989 (UMLS CUI [3,2])
C3258246 (UMLS CUI [3,3])
C0027627 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Malignant neoplasm of breast | Noninfiltrating Intraductal Carcinoma | Lobular carcinoma in situ of breast eligible
Item
patients with any history of breast malignancy including dcis (patients with a history of lobular carcinoma in situ (lcis) are eligible).
boolean
C0006142 (UMLS CUI [1])
C0007124 (UMLS CUI [2])
C0279563 (UMLS CUI [3,1])
C1548635 (UMLS CUI [3,2])
Therapeutic radiology procedure Breast Carcinoma | Chemotherapy Breast Carcinoma | Hormone Therapy Breast Carcinoma
Item
treatment including radiation therapy, chemotherapy, and/or hormonal therapy administered for the currently diagnosed breast cancer prior to study entry. the only exception is hormonal therapy, which may have been given for up to a total of 28 days after diagnosis and before study entry.
boolean
C1522449 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C0279025 (UMLS CUI [3,1])
C0678222 (UMLS CUI [3,2])
Preoperative Chemotherapy
Item
patients who will be receiving preoperative chemotherapy.
boolean
C2347669 (UMLS CUI [1])
Bilateral Malignant Neoplasm | Noninfiltrating Intraductal Carcinoma
Item
bilateral malignancy (including dcis).
boolean
C0677861 (UMLS CUI [1])
C0007124 (UMLS CUI [2])
Malignant Neoplasms Except Malignant neoplasm of breast | Exception Disease Free of | Exception Low Risk Recurrence | Carcinoma in situ of uterine cervix Treated eligible | Malignant melanoma in situ Treated eligible | Colon Carcinoma In situ Treated eligible | Basal cell carcinoma Treated eligible | Squamous cell carcinoma of skin Treated eligible
Item
other non-breast malignancies unless the patient is considered disease-free for 5 years before study entry and is deemed by their physician to be at low risk for recurrence. patients with the following cancers are eligible if diagnosed and treated within the past 5 years: carcinoma in situ of the cervix, melanoma in situ, colon carcinoma in situ, and basal cell and squamous cell carcinoma of the skin.
boolean
C0006826 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C0006142 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C3538919 (UMLS CUI [3,2])
C0679254 (UMLS CUI [3,3])
C0851140 (UMLS CUI [4,1])
C1522326 (UMLS CUI [4,2])
C1548635 (UMLS CUI [4,3])
C0854696 (UMLS CUI [5,1])
C1522326 (UMLS CUI [5,2])
C1548635 (UMLS CUI [5,3])
C0699790 (UMLS CUI [6,1])
C0444498 (UMLS CUI [6,2])
C1522326 (UMLS CUI [6,3])
C1548635 (UMLS CUI [6,4])
C0007117 (UMLS CUI [7,1])
C1522326 (UMLS CUI [7,2])
C1548635 (UMLS CUI [7,3])
C0553723 (UMLS CUI [8,1])
C1522326 (UMLS CUI [8,2])
C1548635 (UMLS CUI [8,3])